Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial
Abstract
Background: Pharmacogenomic (PGx) testing can optimize drug efficacy and minimize toxicity, but prescriber adherence to PGx recommendations remains unclear. We aimed to quantify clinician adherence to international PGx recommendations in a cohort of pediatric oncology patients.
Methods: We reviewed files of children with PGx recommendations generated through the MARVEL-PIC (NCT05667766) trial. Patients were included if ≥12 weeks had passed since their PGx report was released to clinicians. Prescribing events were identified for actionable and relevant PGx recommendations and classified as "explicitly followed," "inadvertently followed," or "not followed." Adherence was assessed by patient, drug, and recommendation.
Results: 2,063 PGx recommendations were available for 216 patients. Sixty‑four (3.1%) recommendations were actionable and relevant to 44 patients and 10 drugs within the 12-week study period. Recommendations were explicitly followed in 57/288 (19.8%) events, inadvertently followed in 145 (50.3%) events, and not followed in 86 (29.9%) prescribing events. Mercaptopurine demonstrated the highest explicit adherence (87.5%). No significant associations were observed between adherence and age group, disease group, drug type, or strength of recommendation.
Conclusion: Adherence to PGx recommendations was very low, highlighting a need to understand barriers to PGx implementation, increase education of healthcare professionals, and consider clinical decision support tools…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 216 participants or records.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.